Institutional investors purchased a net $7.3 million shares of SVRA during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 38.38% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONSONANCE CAPITAL MANAGEMENT LP Bought 2.8 Million shares of Savara Inc
VHCP MANAGEMENT LLC Bought 1.3 Million shares of Savara Inc
GREAT POINT PARTNERS LLC Bought 869.5 Thousand shares of Savara Inc